These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 10556036)

  • 1. Selection for improved protein stability by phage display.
    Jung S; Honegger A; Plückthun A
    J Mol Biol; 1999 Nov; 294(1):163-80. PubMed ID: 10556036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selecting for antibody scFv fragments with improved stability using phage display with denaturation under reducing conditions.
    Brockmann EC; Cooper M; Strömsten N; Vehniäinen M; Saviranta P
    J Immunol Methods; 2005 Jan; 296(1-2):159-70. PubMed ID: 15680160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A semi-synthetic repertoire of intrinsically stable antibody fragments derived from a single-framework scaffold.
    Desiderio A; Franconi R; Lopez M; Villani ME; Viti F; Chiaraluce R; Consalvi V; Neri D; Benvenuto E
    J Mol Biol; 2001 Jul; 310(3):603-15. PubMed ID: 11439027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contributions of a highly conserved VH/VL hydrogen bonding interaction to scFv folding stability and refolding efficiency.
    Tan PH; Sandmaier BM; Stayton PS
    Biophys J; 1998 Sep; 75(3):1473-82. PubMed ID: 9726949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody scFv fragments without disulfide bonds made by molecular evolution.
    Proba K; Wörn A; Honegger A; Plückthun A
    J Mol Biol; 1998 Jan; 275(2):245-53. PubMed ID: 9466907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different equilibrium stability behavior of ScFv fragments: identification, classification, and improvement by protein engineering.
    Wörn A; Plückthun A
    Biochemistry; 1999 Jul; 38(27):8739-50. PubMed ID: 10393549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting.
    Villani ME; Morea V; Consalvi V; Chiaraluce R; Desiderio A; Benvenuto E; Donini M
    Mol Immunol; 2008 May; 45(9):2474-85. PubMed ID: 18313757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-estradiol-17beta single-chain Fv fragments: Generation, characterization, gene randomization, and optimized phage display.
    Kobayashi N; Kato Y; Oyama H; Taga S; Niwa T; Sun P; Ohtoyo M; Goto J
    Steroids; 2008 Dec; 73(14):1485-99. PubMed ID: 18824188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutual stabilization of VL and VH in single-chain antibody fragments, investigated with mutants engineered for stability.
    Wörn A; Plückthun A
    Biochemistry; 1998 Sep; 37(38):13120-7. PubMed ID: 9748318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection, characterization and x-ray structure of anti-ampicillin single-chain Fv fragments from phage-displayed murine antibody libraries.
    Burmester J; Spinelli S; Pugliese L; Krebber A; Honegger A; Jung S; Schimmele B; Cambillau C; Plückthun A
    J Mol Biol; 2001 Jun; 309(3):671-85. PubMed ID: 11397088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased folding stability of TEM-1 beta-lactamase by in vitro selection.
    Kather I; Jakob RP; Dobbek H; Schmid FX
    J Mol Biol; 2008 Oct; 383(1):238-51. PubMed ID: 18706424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Directed evolution, phage display and combination of evolved mutants: a strategy to recover the neutralization properties of the scFv version of BCF2 a neutralizing monoclonal antibody specific to scorpion toxin Cn2.
    Juárez-González VR; Riaño-Umbarila L; Quintero-Hernández V; Olamendi-Portugal T; Ortiz-León M; Ortíz E; Possani LD; Becerril B
    J Mol Biol; 2005 Mar; 346(5):1287-97. PubMed ID: 15713481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stabilization and humanization of a single-chain Fv antibody fragment specific for human lymphocyte antigen CD19 by designed point mutations and CDR-grafting onto a human framework.
    Kügler M; Stein C; Schwenkert M; Saul D; Vockentanz L; Huber T; Wetzel SK; Scholz O; Plückthun A; Honegger A; Fey GH
    Protein Eng Des Sel; 2009 Mar; 22(3):135-47. PubMed ID: 19188138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving in vivo folding and stability of a single-chain Fv antibody fragment by loop grafting.
    Jung S; Plückthun A
    Protein Eng; 1997 Aug; 10(8):959-66. PubMed ID: 9415446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Affinity maturation of phage display antibody populations using ribosome display.
    Groves M; Lane S; Douthwaite J; Lowne D; Rees DG; Edwards B; Jackson RH
    J Immunol Methods; 2006 Jun; 313(1-2):129-39. PubMed ID: 16730741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of the framework core residues on the biophysical properties of immunoglobulin heavy chain variable domains.
    Honegger A; Malebranche AD; Röthlisberger D; Plückthun A
    Protein Eng Des Sel; 2009 Mar; 22(3):121-34. PubMed ID: 19136675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of framework residues H6, H7 and H10 in antibody heavy chains: experimental evidence for a new structural subclassification of antibody V(H) domains.
    Jung S; Spinelli S; Schimmele B; Honegger A; Pugliese L; Cambillau C; Plückthun A
    J Mol Biol; 2001 Jun; 309(3):701-16. PubMed ID: 11397090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cloning and expression of human single-chain Fv antibody against amyloid beta peptide involved in Alzheimer's disease].
    Cai J; Wang SZ; Peng Y; Zhong YW; Ji ZJ; Yuan JG; Qiang BQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct; 25(5):557-62. PubMed ID: 14650158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Construction of human phage-displayed scFv library and selection of the ScFv against rabies virus].
    Zhao XL; Yin J; Wang H; Jiang M; Hou XJ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Mar; 20(2):243-7. PubMed ID: 15191736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent.
    Beiboer SH; Reurs A; Roovers RC; Arends JW; Whitelegg NR; Rees AR; Hoogenboom HR
    J Mol Biol; 2000 Feb; 296(3):833-49. PubMed ID: 10677285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.